Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Tanvex Biopharma (6541) Financial Statements

Tanvex Biopharma Financial Overview

Tanvex Biopharma's market cap is currently NT$7.47B. The company's EPS TTM is NT$-5.59; its P/E ratio is -5.00; Tanvex Biopharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 400.97MNT$ 34.68MNT$ 61.41MNT$ 22.40MNT$ 5.41M
Gross ProfitNT$ -440.71MNT$ 8.29MNT$ 59.70MNT$ -19.35MNT$ 3.55M
Operating IncomeNT$ -1.39BNT$ -1.36BNT$ -2.10BNT$ -1.59BNT$ -1.50B
EBITDANT$ -1.02BNT$ -1.04BNT$ -1.75BNT$ -1.30BNT$ -1.25B
Net IncomeNT$ -1.50BNT$ -1.38BNT$ -2.14BNT$ -1.64BNT$ -1.54B
Balance Sheet
Cash & Short-Term InvestmentsNT$ 878.71MNT$ 376.96MNT$ 380.75MNT$ 786.23MNT$ 2.22B
Total AssetsNT$ 7.96BNT$ 2.74BNT$ 2.76BNT$ 3.42BNT$ 4.71B
Total DebtNT$ 1.58BNT$ 1.65BNT$ 1.73BNT$ 1.84BNT$ 1.76B
Net DebtNT$ 699.69MNT$ 1.27BNT$ 1.35BNT$ 1.05BNT$ -463.95M
Total LiabilitiesNT$ 2.27BNT$ 1.84BNT$ 1.94BNT$ 2.03BNT$ 1.92B
Stockholders' EquityNT$ 5.69BNT$ 893.31MNT$ 821.11MNT$ 1.39BNT$ 2.79B
Cash Flow
Free Cash FlowNT$ -1.68BNT$ -1.26BNT$ -1.51BNT$ -1.43BNT$ -1.42B
Operating Cash FlowNT$ -1.01BNT$ -1.15BNT$ -1.43BNT$ -1.33BNT$ -1.39B
Investing Cash FlowNT$ 301.80MNT$ -109.25MNT$ -83.57MNT$ -97.35MNT$ -24.68M
Financing Cash FlowNT$ 1.14BNT$ 1.26BNT$ 1.08BNT$ -123.29MNT$ 1.60B

Currency in TWD

Tanvex Biopharma Earnings and Revenue History

-3B-1.5B01.5B-750000 %-500000 %-250000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Tanvex Biopharma Liabilities to Assets

03B6B9B0 %25 %50 %75 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Tanvex Biopharma Cash Flow

-3B-2B-1B01B2B3B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Tanvex Biopharma Forecast EPS vs Actual EPS

-2-1.7-1.5-1.2-1-0.7-0.5Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss
Earnings >